Of the myriad reasons for seeking medical consultation, breast pain, or mastalgia, stands as one of the most common complaints in both primary care and specialty breast clinics. While it affects up to 70% of women at some point in their lives, its presence often triggers significant anxiety due to the pervasive fear of breast cancer. However, it is crucial to understand that mastalgia, particularly when it is the sole symptom, is rarely associated with malignancy. Effective management hinges on a systematic and empathetic approach that involves a thorough understanding of its causes (etiology), a comprehensive diagnostic process (evaluation), and a stepwise, patient-centered plan for relief (treatment).
Etiology of Mastalgia: Understanding the Origins of Breast Pain
The origins of breast pain are diverse, and classifying the pain is the first and most critical step in determining its cause. Mastalgia is broadly categorized into three distinct types: cyclical, non-cyclical, and extramammary.
1. Cyclical Mastalgia
This is the most common form, accounting for approximately two-thirds of all cases. As the name suggests, cyclical mastalgia is intrinsically linked to the menstrual cycle.
- Characteristics: The pain is typically described as a dull, heavy, or aching sensation. It is often bilateral (affecting both breasts), though it can be more severe in one, and is usually most prominent in the upper-outer quadrants of the breasts, sometimes radiating to the axilla (armpit) and arm. It typically begins during the luteal phase of the menstrual cycle (the one to two weeks preceding menstruation) and resolves with the onset of menses.
- Pathophysiology: The precise cause is not fully elucidated, but it is strongly believed to be hormonal. The prevailing theory points to an abnormal response of breast tissue to normal hormonal fluctuations of estrogen and progesterone. Estrogen stimulates the proliferation of breast ducts, while progesterone promotes the growth of the lobules and stroma. An imbalance, such as relative estrogen dominance or progesterone deficiency, can lead to excessive stimulation, causing edema (fluid retention), and tenderness in the breast tissue. Another related hypothesis involves prolactin, a hormone that can enhance the effects of estrogen on the breast. Some women with cyclical mastalgia may have heightened sensitivity to normal prolactin levels, leading to pain and swelling.
2. Non-cyclical Mastalgia
This type of breast pain is unrelated to the menstrual cycle and is less common, accounting for about one-quarter of cases.
- Characteristics: Non-cyclical pain is often described as sharp, burning, or throbbing. It is typically unilateral (affecting one breast), constant or intermittent, and localized to a specific area. It is more common in women in their 40s and 50s.
- Pathophysiology: The causes are more varied and often relate to a specific anatomical or pathological issue within the breast. These can include:
- Macrocysts: Large, fluid-filled cysts can stretch the surrounding breast tissue, causing localized pain.
- Ductal Ectasia: The widening and inflammation of a milk duct beneath the nipple can cause a sharp, burning pain.
- Mastitis or Abscess: A breast infection, more common in lactating women but possible in non-lactating women, causes intense pain, redness, swelling, and warmth.
- Trauma: An injury to the breast can lead to a hematoma (bruise) or fat necrosis (damage to fatty tissue), resulting in a painful lump.
- Previous Breast Surgery: Scar tissue, nerve entrapment, or inflammation from a prior biopsy or cosmetic surgery can be a source of chronic pain.
- Medications: Certain drugs are known to cause mastalgia as a side effect. These include hormonal therapies (oral contraceptives, hormone replacement therapy), certain antidepressants (SSRIs), antihypertensives (e.g., spironolactone), and some antipsychotics.
- Idiopathic: In many cases of non-cyclical pain, a specific cause cannot be identified.
3. Extramammary Pain
This category, accounting for less than 10% of cases, refers to pain that is felt in the breast but originates from a different anatomical location.
- Characteristics: The quality of the pain can vary widely depending on the source. It is crucial for the clinician to consider this possibility, especially when a thorough breast examination is normal.
- Pathophysiology: Common sources of referred pain include:
- Chest Wall Pain: This is the most frequent cause. Conditions like costochondritis (inflammation of the cartilage connecting the ribs to the sternum), intercostal muscle strain, or a rib fracture can mimic breast pain.
- Thoracic Spine: Radiculopathy from a pinched nerve in the upper back can radiate pain forward to the chest wall and breast.
- Cardiac Pain: While uncommon, angina (pain from reduced blood flow to the heart) can present as chest pain that may be perceived as originating in the breast, particularly the left breast. This is a critical diagnosis to exclude in patients with cardiovascular risk factors.
- Other Sources: Gallbladder disease, gastroesophageal reflux disease (GERD), or even psychological conditions like anxiety can manifest with symptoms of chest and breast pain.
Evaluation of Mastalgia: A Systematic Diagnostic Approach
The primary goal of evaluating mastalgia is twofold: to reassure the patient by ruling out malignancy and to identify the underlying cause to guide treatment.
Step 1: Comprehensive History The patient’s history is the most valuable diagnostic tool. Key questions include:
- Pain Details: A detailed description of the pain (quality, location, severity, duration) is essential.
- Cyclical Nature: The relationship to the menstrual cycle is the most important question to differentiate cyclical from non-cyclical pain. A pain diary, where the patient charts her pain severity for 2-3 months, can be invaluable.
- Associated Symptoms: Inquire about nipple discharge, palpable lumps, or skin changes (dimpling, redness, rashes).
- Medical and Surgical History: Note any prior breast biopsies, surgeries, injuries, or known benign breast conditions.
- Medication Review: A thorough review of all medications, including over-the-counter drugs and supplements, is necessary.
- Risk Factor Assessment: While pain is rarely a sign of cancer, assessing the patient’s risk factors for breast cancer (age, family history, personal history) helps contextualize the complaint and guide imaging decisions.
Step 2: Clinical Breast Examination (CBE) A careful physical examination is performed to identify any abnormalities and to attempt to reproduce the pain.
- Inspection: The breasts are visually inspected for asymmetry, skin changes, or nipple retraction.
- Palpation: The clinician will systematically palpate the entire breast tissue, the axilla, and the surrounding chest wall. This helps identify any lumps, areas of thickening, or tenderness. Importantly, pressing on the ribs and sternum can help diagnose costochondritis if it reproduces the patient’s specific pain.
Step 3: Diagnostic Imaging Imaging is not always necessary but is used to investigate focal findings on examination or to provide reassurance, particularly in women over 35 or with significant risk factors.
- Mammography and Ultrasound: The choice of imaging depends on age and clinical findings. For women under 30, ultrasound is typically the initial modality due to the density of their breast tissue. For women over 40, a mammogram is the standard, often supplemented with a targeted ultrasound of the painful area. The primary purpose of imaging is to rule out an underlying malignancy or identify a structural cause like a cyst. In most cases of mastalgia, imaging is normal.
- MRI: Breast MRI is not a standard tool for evaluating pain and is reserved for specific, complex clinical scenarios.
Treatment of Mastalgia: A Stepwise Management Plan
Treatment should be tailored to the type and severity of the pain, beginning with the least invasive options.
Tier 1: Reassurance and Conservative Measures (First-Line) For the vast majority of women, particularly those with cyclical pain and normal examinations, this tier is sufficient.
- Reassurance and Education: The most powerful intervention is providing a clear explanation of the benign nature of the pain and the low risk of cancer. This alone alleviates the associated anxiety and can reduce pain perception in up to 85% of patients.
- Mechanical Support: A properly fitted, supportive bra worn both day and night (such as a soft sports bra) can significantly reduce pain by minimizing breast movement and tension on the Cooper’s ligaments.
- Lifestyle and Dietary Modification:
- Low-Fat Diet: Some studies have shown that a diet deriving less than 20% of calories from fat can reduce cyclical mastalgia, possibly by altering estrogen metabolism.
- Caffeine Reduction: The link between caffeine (found in coffee, tea, chocolate, and soft drinks) and breast pain is controversial, with conflicting evidence. However, a trial of caffeine elimination for 2-3 months is a simple, harmless recommendation.
- Topical NSAIDs: Applying a nonsteroidal anti-inflammatory drug, such as diclofenac gel, directly to the painful area provides localized relief with minimal systemic side effects, making it an excellent early option.
Tier 2: Non-Prescription Supplements (Use with Caution) While historically popular, the evidence for many supplements is weak.
- Evening Primrose Oil (EPO): This supplement contains gamma-linolenic acid (GLA). Older studies suggested a benefit, but large, high-quality systematic reviews (such as by the Cochrane Collaboration) have concluded that it is no more effective than a placebo.
- Vitamin E: Similar to EPO, evidence supporting its use is limited and inconsistent.
Tier 3: Pharmacological Therapy (For Severe, Refractory Pain) When pain is severe and significantly impacts a patient’s quality of life, prescription medications may be considered. These agents have substantial side effect profiles and require careful patient counseling.
- Tamoxifen: A selective estrogen receptor modulator (SERM) that blocks the effect of estrogen on breast tissue. Low doses (e.g., 10 mg/day) are highly effective, providing relief in 70-90% of cases. However, potential side effects include hot flashes, vaginal dryness, and a small but serious risk of blood clots and endometrial cancer.
- Danazol: A synthetic steroid that suppresses ovulation and ovarian hormone production. It is very effective but is rarely used today due to significant and often irreversible androgenic side effects, such as weight gain, acne, hirsutism (excess hair growth), and voice deepening.
- Bromocriptine: A dopamine agonist that lowers prolactin levels. Its use is limited by side effects like nausea, dizziness, and headache.
- GnRH Agonists (e.g., Goserelin): These drugs induce a temporary “medical menopause” and are extremely effective but are reserved for the most severe and intractable cases due to significant menopausal side effects and the risk of bone density loss with prolonged use.
Managing Non-Cyclical and Extramammary Pain
Treatment for these types focuses on addressing the underlying cause: aspirating a painful cyst, prescribing antibiotics for mastitis, using NSAIDs for costochondritis, or referring for physical therapy for musculoskeletal issues.
In conclusion, mastalgia is a prevalent and distressing symptom that is overwhelmingly benign. A successful approach is rooted in a careful classification of the pain, a thorough clinical evaluation to provide reassurance and rule out pathology, and a graduated therapeutic strategy that prioritizes conservative measures. By moving through these steps systematically, clinicians can effectively alleviate patient anxiety and provide tangible relief, improving the quality of life for those affected by this common condition.
References
- American College of Obstetricians and Gynecologists (ACOG). (2022). Practice Bulletin No. 164: Diagnosis and Management of Benign Breast Disorders. Obstetrics & Gynecology, 140(4), e224-e237.
- Gumm, R., & Gaskell, L. (2020). Mastalgia. InnovAiT: Education and inspiration for general practice, 13(1), 30-36.
- Salzman, B., Fleegle, S., & Tully, A. S. (2012). Common Breast Problems. American Family Physician, 86(4), 343-349.
- Srivastava, A., Mansel, R. E., & Arvind, N. (2007). Evidence-based management of mastalgia: a meta-analysis of randomised trials. The Breast, 16(5), 503-512.
- Rosolowich, V., Saettler, E., & Szuck, B. (2006). Mastalgia. Journal of Obstetrics and Gynaecology Canada, 28(1), 49-57.
- Goyal, A. (2011). Breast Pain. BMJ Clinical Evidence, 2011, 0812.
- Smith, R. L., Pruthi, S., & Fitzpatrick, L. A. (2004). Evaluation and management of breast pain. Mayo Clinic Proceedings, 79(3), 353-372.
